Martin Rowe

Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death

S. A. Henderson, Martin Rowe, C D Gregory et al. · Cell · 1991 · 1.2K citations

Apoptosis, Immunology, B Cells +8

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

Roland Schmitz, Ryan M. Young, Michele Ceribelli et al. · Nature · 2012 · 908 citations · Full text

Lymphoid Neoplasia, Functional Genomics, Immunology +5

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.

Martin Rowe, David Rowe, Christopher D. Gregory et al. · The EMBO Journal · 1987 · 723 citations · Full text

Lymphoid Neoplasia, Lymphocyte Development, Lymphoma Cells +6

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

Gorm Pallesen, Stephen Hamilton‐Dutoit, Martin Rowe et al. · The Lancet · 1991 · 707 citations

Lymphoid Neoplasia, Immunology, Pathology +9

Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death.

S. A. Henderson, David Huen, Martin Rowe et al. · Proceedings of the National Academy of Sciences · 1993 · 600 citations · Full text

Lymphoid Neoplasia, Human B Cells, Epstein-barr Virus +13